Literature DB >> 18040662

Insulin therapy in the intensive care unit should be targeted to maintain blood glucose between 4.4 mmol/l and 6.1 mmol/l.

G Van den Berghe1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18040662     DOI： 10.1007/s00125-007-0878-7

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  30 in total

1.  Strict blood glucose control with insulin during intensive care after cardiac surgery: impact on 4-years survival, dependency on medical care, and quality-of-life.

Authors:  Catherine Ingels; Yves Debaveye; Ilse Milants; Erik Buelens; Ann Peeraer; Yves Devriendt; Tom Vanhoutte; Aurelie Van Damme; Miet Schetz; Pieter J Wouters; Greet Van den Berghe
Journal:  Eur Heart J       Date:  2006-04-11       Impact factor: 29.983

2.  Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels.

Authors:  Troels Krarup Hansen; Steffen Thiel; Pieter Jozef Wouters; Jens Sandahl Christiansen; Greet Van den Berghe
Journal:  J Clin Endocrinol Metab       Date:  2003-03       Impact factor: 5.958

3.  Survival benefits of intensive insulin therapy in critical illness: impact of maintaining normoglycemia versus glycemia-independent actions of insulin.

Authors:  Björn Ellger; Yves Debaveye; Ilse Vanhorebeek; Lies Langouche; Annapaula Giulietti; Evelyne Van Etten; Paul Herijgers; Chantal Mathieu; Greet Van den Berghe
Journal:  Diabetes       Date:  2006-04       Impact factor: 9.461

4.  Effects of insulin treatment on cause-specific one-year mortality and morbidity in diabetic patients with acute myocardial infarction. DIGAMI Study Group. Diabetes Insulin-Glucose in Acute Myocardial Infarction.

Authors:  K Malmberg; L Rydén; A Hamsten; J Herlitz; A Waldenström; H Wedel
Journal:  Eur Heart J       Date:  1996-09       Impact factor: 29.983

5.  Clinical effects of hyperglycemia in the cardiac surgery population: the Portland Diabetic Project.

Authors:  Anthony P Furnary; YingXing Wu
Journal:  Endocr Pract       Date:  2006 Jul-Aug       Impact factor: 3.443

6.  Protection of hepatocyte mitochondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients.

Authors:  Ilse Vanhorebeek; Rita De Vos; Dieter Mesotten; Pieter J Wouters; Christiane De Wolf-Peeters; Greet Van den Berghe
Journal:  Lancet       Date:  2005 Jan 1-7       Impact factor: 79.321

7.  Cost analysis of intensive glycemic control in critically ill adult patients.

Authors:  James Stephen Krinsley; Richard L Jones
Journal:  Chest       Date:  2006-03       Impact factor: 9.410

8.  Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting.

Authors:  Anthony P Furnary; Guangqiang Gao; Gary L Grunkemeier; YingXing Wu; Kathryn J Zerr; Stephen O Bookin; H Storm Floten; Albert Starr
Journal:  J Thorac Cardiovasc Surg       Date:  2003-05       Impact factor: 5.209

9.  Effect of intensive insulin therapy on insulin sensitivity in the critically ill.

Authors:  Lies Langouche; Sarah Vander Perre; Pieter J Wouters; André D'Hoore; Troels Krarup Hansen; Greet Van den Berghe
Journal:  J Clin Endocrinol Metab       Date:  2007-07-31       Impact factor: 5.958

10.  Analysis of healthcare resource utilization with intensive insulin therapy in critically ill patients.

Authors:  Greet Van den Berghe; Pieter J Wouters; Katrien Kesteloot; Daniel E Hilleman
Journal:  Crit Care Med       Date:  2006-03       Impact factor: 7.598
View more
  12 in total

1.  No, the glycaemic target in the critically ill should not be < or = 6.1 mmol/l.

Authors:  J M Miles; M M McMahon; W L Isley
Journal:  Diabetologia       Date:  2007-12-20       Impact factor: 10.122

2.  [Stress hyperglycemia--effect on morbidity and mortality in acute patients].

Authors:  Christian Madl; Ulrike Holzinger; Reinhard Kitzberger; Joanna Warszawska
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

Review 3.  Tight perioperative glycemic control using an artificial endocrine pancreas.

Authors:  Kazuhiro Hanazaki; Hiromichi Maeda; Takehiro Okabayashi
Journal:  Surg Today       Date:  2009-12-29       Impact factor: 2.549

4.  A dead heat: target normal glucose levels in the intensive care unit--but with caution.

Authors:  J B Buse
Journal:  Diabetologia       Date:  2008-06       Impact factor: 10.122

Review 5.  Progressive artificial endocrine pancreas: The era of novel perioperative blood glucose control for surgery.

Authors:  Yuuki Tsukamoto; Takehiro Okabayashi; Kazuhiro Hanazaki
Journal:  Surg Today       Date:  2011-09-16       Impact factor: 2.549

6.  Technical challenges and clinical outcomes of using a closed-loop glycemic control system in the hospital.

Authors:  Takehiro Okabayashi; Akihito Kozuki; Tatsuaki Sumiyoshi; Yasuo Shima
Journal:  J Diabetes Sci Technol       Date:  2013-01-01

Review 7.  Anaesthetic perioperative management of patients with pancreatic cancer.

Authors:  Lesley De Pietri; Roberto Montalti; Bruno Begliomini
Journal:  World J Gastroenterol       Date:  2014-03-07       Impact factor: 5.742

8.  Effect of early intensive insulin therapy on immune function of aged patients with severe trauma.

Authors:  Junxun Ma; Xiaodong Zhao; Qin Su; Wei Dang; Xian Zhang; Xiaoling Yuan; Jianbo Zhang; Hongsheng Liu; Yuhong Qin; Yongming Yao; Hong Shen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-06-09

Review 9.  Current topics in glycemic control by wearable artificial pancreas or bedside artificial pancreas with closed-loop system.

Authors:  Kazuhiro Hanazaki; Masaya Munekage; Hiroyuki Kitagawa; Tomoaki Yatabe; Eri Munekage; Mai Shiga; Hiromichi Maeda; Tsutomu Namikawa
Journal:  J Artif Organs       Date:  2016-05-03       Impact factor: 1.731

10.  Effect of intensive insulin therapy using a closed-loop glycemic control system in hepatic resection patients: a prospective randomized clinical trial.

Authors:  Takehiro Okabayashi; Isao Nishimori; Hiromichi Maeda; Koichi Yamashita; Tomoaki Yatabe; Kazuhiro Hanazaki
Journal:  Diabetes Care       Date:  2009-05-12       Impact factor: 19.112
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.